213 related articles for article (PubMed ID: 25359262)
21. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
22. Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.
Tang Y; Yu X; Zhang X; Xia W; Wu X; Zou X; Li H; Huang X; Stefan H; Chen Q; Gong Q; Zhou D
Neuroscience; 2015 Sep; 303():595-603. PubMed ID: 26197226
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density in adult patients treated with various antiepileptic drugs.
Beniczky SA; Viken J; Jensen LT; Andersen NB
Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
[TBL] [Abstract][Full Text] [Related]
24. Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients.
El-Haggar SM; Mostafa TM; Allah HMS; Akef GH
Arq Neuropsiquiatr; 2018 Jul; 76(7):452-458. PubMed ID: 30066796
[TBL] [Abstract][Full Text] [Related]
25. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
[TBL] [Abstract][Full Text] [Related]
26. Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics.
Gefroh-Grimes HA; Gidal BE
Acta Neurol Scand; 2016 Jan; 133(1):4-16. PubMed ID: 25996875
[TBL] [Abstract][Full Text] [Related]
27. Lacosamide Lowers Valproate and Levetiracetam Levels.
Tountopoulou M; Weschke B; Kaindl AM
Neuropediatrics; 2017 Jun; 48(3):188-189. PubMed ID: 28324910
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
Cardona AF; Rojas L; Wills B; Bernal L; Ruiz-Patiño A; Arrieta O; Hakim EJ; Hakim F; Mejía JA; Useche N; Bermúdez S; Carranza H; Vargas C; Otero J; Mayor LC; Ortíz LD; Franco S; Ortíz C; Gil-Gil M; Balaña C; Zatarain-Barrón ZL
J Neurooncol; 2018 Jan; 136(2):363-371. PubMed ID: 29177594
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
[TBL] [Abstract][Full Text] [Related]
31. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study.
Lim DA; Tarapore P; Chang E; Burt M; Chakalian L; Barbaro N; Chang S; Lamborn KR; McDermott MW
J Neurooncol; 2009 Jul; 93(3):349-54. PubMed ID: 19169651
[TBL] [Abstract][Full Text] [Related]
32. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Delanty N; Jones J; Tonner F
Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
[TBL] [Abstract][Full Text] [Related]
34. Levetiracetam-induced interstitial nephritis in a patient with glioma.
Mahta A; Kim RY; Kesari S
J Clin Neurosci; 2012 Jan; 19(1):177-8. PubMed ID: 22071460
[TBL] [Abstract][Full Text] [Related]
35. P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy.
Oberndorfer S; Piribauer M; Marosi C; Lahrmann H; Hitzenberger P; Grisold W
J Neurooncol; 2005 May; 72(3):255-60. PubMed ID: 15937649
[TBL] [Abstract][Full Text] [Related]
36. First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
van der Meer PB; Dirven L; Fiocco M; Vos MJ; Kouwenhoven MCM; van den Bent MJ; Taphoorn MJB; Koekkoek JAF
Epilepsia; 2021 May; 62(5):1119-1129. PubMed ID: 33735464
[TBL] [Abstract][Full Text] [Related]
37. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
Maitre NL; Smolinsky C; Slaughter JC; Stark AR
J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
[TBL] [Abstract][Full Text] [Related]
38. In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
Shallcross R; Bromley RL; Cheyne CP; García-Fiñana M; Irwin B; Morrow J; Baker GA; ;
Neurology; 2014 Jan; 82(3):213-21. PubMed ID: 24401687
[TBL] [Abstract][Full Text] [Related]
39. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
[TBL] [Abstract][Full Text] [Related]
40. Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.
Iuchi T; Kuwabara K; Matsumoto M; Kawasaki K; Hasegawa Y; Sakaida T
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1158-62. PubMed ID: 25511789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
